Sygnature Discovery
Generated by Meeveem AI
"Connected drug discovery through chemistry, bioscience and protein research"
About Sygnature Discovery
Sygnature Discovery is a drug discovery contract research organisation. It combines medicinal chemistry, bioscience, protein science and drug metabolism and pharmacokinetics to help biotechnology and pharmaceutical teams investigate new medicines. Its UK research teams work across Nottingham, Alderley Park, Macclesfield and Glasgow, alongside colleagues in Canada. Roles span laboratory research, computational chemistry and scientific project work. The group brings together the integrated capabilities of Peak Proteins, NuChem Sciences and SB Drug Discovery. The group averaged 1,022 employees, including directors, in the year to March 2025.
1022
Team Members
2004
Founded
Contract Research
Sector
On-Site
Work Environment
Our Vision
Sygnature aims to improve discovery through connected science and expert collaboration. It is expanding research capabilities and applying new tools to help customers progress promising medicines.
Our Mission
Sygnature helps life science teams turn research ideas into candidates for new medicines. It brings chemistry, bioscience and drug metabolism expertise into coordinated discovery programmes.